Hence, we speculate that suppression of GSK-3β and ensuing activation of the NRF2-dependent antioxidant response is a critical mechanism underlying the protective effect of ISL against LPS-induced cognitive impairment. The gene discussed is GSK3B; the disease is Cognitive impairment.